Review Article

Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review

Table 1

Summary of studies addressed MSCs in acute pancreatitis. L-arg: L-arginine; Na TCA: sodium taurocholate solution; TCA: taurocholic acid solution; LPS: lipopolysaccharide; rBM-MSCs: rat bone marrow mesenchymal stromal cells; hBM-MSCs: human bone marrow mesenchymal stromal cells; UCMSCs: umbilical cord mesenchymal stromal cells; hUCMSCs: human umbilical cord mesenchymal stromal cells; rFMMSCs: rat fetal membrane mesenchymal stromal cells; SD rats: Sprague Dawley rats; mir-9: microRNA-9; N/A: not applicable; PBS: phosphate buffer saline.

AuthorPancreatitis induction methodSource of MSCsDose of MSCsRoute of MSC infusionTimeline of MSC therapySpecific treatment of MSCsOutcome
Treatment time pointScarification timelineSerum amylase and lipaseHistological feature of pancreasMechanism of action of infused MSCs

Qu et al., [53]L-argrBM-MSCs1 ml cell suspension: 1 × 107 cells/mlTail vein of SD rats4 daysAfter 7, 14, and 21 daysN/ADecreasedDecreased(i) Pancreatic lineage differentiation

Qian et al., [54]Na TCA and CaeruleinrBM-MSCs1 × 107cells/kgTail vein of SD rats24 hrs.After 3 daysmiR-9 modified BM-MSCsDecreasedDecreased(i) Immunomodulatory effect
(ii) Antiapoptotic effect
(iii) Antioxidant effect
(iv) Enhancement of regeneration of damaged pancreas
(v) Deliver miR-9 to the injured pancreas or peripheral blood mononuclear cell (PBMC), which can target the NF-κB1/p50 gene and inhibit the NF-κB signaling pathway

He et al., [47]Na TCAhBM-MSCs2.0 × 106 cellsTail vein of C57BL/6 mice6 hrs.N/AhBM-MSCs transfected with TSG-6 siRNADecreasedDecreased(i) Immunomodulatory effect

Jung et al., [45]Cerulein and sequential LPShBM-MSCs1 × 106 cellsTail vein of SD rats24 hrsAfter 3 daysN/ADecreasedDecreased(i) Immunomodulatory effect
(ii) Antioxidant effect

Yin et al., [48]L-argrBM-MSCs1 × 106 cellsTail vein of SD rats3 hrs.After 1, 2, and 3 daysN/ADecreasedDecreased(i) Immunomodulatory effect

Qian et al., [46]Na TCArBM-MSCs1 × 107 cells/ml/kgTail vein of SD rats1, 5, 7, and 10 daysN/ABM-MSCs pretreated with SDF-1αDecreasedDecreased(i) Immunomodulatory effect
(ii) Angiogenesis-enhancing effect

Tu et al., [52]Na TCArBM-MSCs2 × 106 cells/mlDorsal penile vein of SD rats1 hr.After 6, 12, 24, and 48 hrs.N/ADecreasedDecreasedN/A

Chen et al., [50]Na TCABM-MSCs (source not specified)1 × 106 cellsTail vein of SD rats0 hr.After 6 hrs.N/ADecreasedDecreasedN/A
0, 6 hrs.After 12 hrs.
0, 6, and 12 hrs.After 24 hrs.

Tu et al., [51]Deoxy-STCrBM-MSCs2 ml cell suspension: 1 × 106 cells/mlTail vein of SD ratsN/AAfter 6, 24, and 72 hrs.N/ADecreasedDecreased(i) Immunomodulatory effect
(ii) Antioxidant effect

Zhao et al., [49]TCArBM-MSCs5–7 × 107 cellsTail vein of SD rats24 hrs.After 72 hrs.N/ADecreasedDecreased(i) Immunomodulatory effect

Jung et al., [44]Mild acute pancreatitis: cerulein
Severe acute pancreatitis: Na TCA
hBM-MSCsN/ATail vein of SD ratsN/AAfter 3 daysN/ADecreasedDecreased(i) Immunomodulatory effect
(ii) Antiapoptotic effect (apoptosis of acinar cells was reduced in severe acute pancreatitis than in mild acute pancreatitis)

Hua et al., [57]Na TCAhUCMSCs1 × 106 cells in 200 μl salineTail vein of SD rats12 hrsAfter 3 daysANGPT1-transfected hUCMSCsDecreasedDecreased(i) Immunomodulatory effect
(ii) Angiogenesis-enhancing effect

Yang et al., [56]Na TCAhUCMSCs5 × 106 cells/kgTail vein of SD rats0, 1, 6, and 12 hrsAfter 48 hrs.N/ADecreasedDecreased(i) Immunomodulatory effect
5 × 104, 5 × 106, and 1 × 107 cells/kg1 hr
5 × 1066 hrs

Meng et al., [55]Na TCAhUSMSCs1 × 107 cells/kgTail vein of SD rats12 hrsAfter 1, 3, and 5 daysN/ADecreasedDecreased(i) Antiapoptotic effect (reduce acinar cell apoptosis)
(ii) Immunomodulatory effect

Kim et al., [43]Na TCACanine adipose tissue-derived MSCs2 × 106 cells/kg in 200 μl PBSTail vein of SD ratsN/AAfter 3 daysN/ADecreasedDecreased(i) Immunomodulatory effect

K et al., 2016TCArFMMSCs1 × 106 cells in 200 ul PBSPenile vein of August Copenhagen Irish ratsN/AAfter 4 daysN/ADecreasedDecreased(i) Immunomodulatory effect